Ischemic stroke is a common disorder associated with significant morbidity
and mortality. Results of several pivotal clinical trials completed within
the last decade have helped refine stroke prevention and treatment strategi
es. Endarterectomy for symptomatic carotid artery stenosis, anticoagulation
in atrial fibrillation, and IV t-PA treatment of hyperacute ischemic strok
e may reduce the burden of stroke. Ongoing studies are addressing newly rec
ognized risk factors, such as aortic arch and intracranial atherosclerosis,
as well as neuroprotective agents and locally delivered thrombolytics. Suc
cessful patient management requires a targeted clinical approach based on v
ascular localization and risk factor assessment.